deltatrials
Unknown PHASE2 INTERVENTIONAL 1-arm NCT01329354

Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy

Phase II Clinical Trial of Immunotherapy With Rituximab and Autologous Effector Lymphocytes in Patients With Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy

Sponsor: Clinica Universidad de Navarra, Universidad de Navarra

Conditions Autologous Effector Lymphocytes Follicular Lymphoma Follicular Non-Hodgkin´s Lymphoma
Interventions Autologous effector lymphocytes expanded ex-vivo
Updated 6 times since 2017 Last updated: Oct 23, 2017 Started: Mar 31, 2011 Primary completion: Nov 30, 2019 Completion: Nov 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Autologous Effector Lymphocytes and Follicular Lymphoma and is currently ongoing. Clinica Universidad de Navarra, Universidad de Navarra leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Dec 2019 · 18 months · monthly snapshotActive Not Recruiting~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – present · 22 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE2

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE2

  4. Dec 2019 — Jan 2021 [monthly]

    Unknown Status PHASE2

    Status: Active Not Recruiting → Unknown Status

  5. Jun 2018 — Dec 2019 [monthly]

    Active Not Recruiting PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE2

    First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Clinica Universidad de Navarra, Universidad de Navarra
  • Spanish National Health System
Data source: Clinica Universidad de Navarra, Universidad de Navarra

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations